Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aquatabs is a point-of-use water purification product containing sodium dichloroisocyanurate (NaDCC) as the active ingredient. Manufactured by Medentech, these effervescent tablets are designed to disinfect household drinking water by releasing a precise dose of free chlorine (hypochlorous acid). This process effectively reduces microbial contamination, including enteric pathogens such as *E. coli*, which are primary causes of diarrheal diseases. The International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) has evaluated Aquatabs in large-scale randomized trials to assess their impact on reducing diarrhea prevalence among children in rural settings where tubewell water is a primary source. The tablets provide a stable and portable method for water treatment, ensuring safety during storage and transport by providing residual protection against recontamination.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aquatabs.